Alpha 2.0
Login Register
» Articles » PMID: 22500880

Concerns About the Jikei Heart Study

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2012 Apr 17
PMID 22500880
Citations 10
Authors
Yoshiki Yui
Affiliations
Soon will be listed here.
Citing Articles

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.

Ozieranski P, Saito H, Rickard E, Mulinari S, Ozaki A Global Health. 2023; 19(1):14.

PMID: 36869318 PMC: 9985252. DOI: 10.1186/s12992-022-00902-9.

Changes in Drug Utilization After Publication of Clinical Trials and Drug-Related Scandals in Japan: An Interrupted Time Series Analysis, 2005-2017.

Fukuma S, Ikenoue T, Yamada Y, Saito Y, Green J, Nakayama T J Epidemiol. 2020; 31(7):410-416.

PMID: 32624520 PMC: 8187611. DOI: 10.2188/jea.JE20200181.

Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.

Yui Y NPJ Regen Med. 2018; 3:7.

PMID: 29581888 PMC: 5862830. DOI: 10.1038/s41536-018-0047-2.

Scientific Misconduct and Social Media: Role of Twitter in the Stimulus Triggered Acquisition of Pluripotency Cells Scandal.

Sugawara Y, Tanimoto T, Miyagawa S, Murakami M, Tsuya A, Tanaka A J Med Internet Res. 2017; 19(2):e57.

PMID: 28246071 PMC: 5350454. DOI: 10.2196/jmir.6706.

Questions Surrounding iPS Cells in Japan.

Yui Y Int J Stem Cells. 2016; 9(1):1-2.

PMID: 27426079 PMC: 4961097. DOI: 10.15283/ijsc.2016.9.1.1.